Short answer
SHOULDER INNOVATIONS, INC. (SI) filed an 8-K current report with the SEC on August 6, 2026 reporting Item 2.02 (Results of Operations and Financial Condition), Item EX-99.1 (Exhibit EX-99.1). Q2 2026 results for quarter ended June 30, 2026 released August 6, 2026.
SHOULDER INNOVATIONS, INC. 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- Q2 2026 results for quarter ended June 30, 2026 released August 6, 2026
- Detailed financial results and management commentary available in Exhibit 99.1
- Disclosure furnished under Item 2.02, limiting Section 18 liability and automatic incorporation into other filings
Item EX-99.1 · Exhibit EX-99.1
- Q2 revenue $17.2M, up 56%, with implant systems sold up approximately 50% to 2,238
- Gross margin improved to 78.3% from 76.2%, supported by higher pricing and cost reductions
- Full-year 2026 revenue guidance raised to $67M-$69M, implying approximately 42%-46% growth
- Operating loss widened to $10.0M as SG&A rose 56% and R&D increased 141% for commercial and product investments
- New credit facilities provide up to $50M, refinancing existing debt and adding undrawn working-capital capacity
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other SHOULDER INNOVATIONS, INC. 8-K filings
Get the next SI 8-K as it lands
Follow SI for push alerts, or ask the research agent what this filing means.